Jiangsu Vcare Selected Among "2024 China’s Top 500 Hidden Unicorn Enterprises"
Published Time:
2024-11-18 18:09
Source:
At the 2024 China Hidden Unicorn 500 Summit, theDevelopment Report on China’s Top 500 Hidden Unicorn Enterprises 2024was released.Jiangsu Vcare Pharmatech Co., Ltd.(Jiangsu Vcare) debuted on this list, showcasing its strong technical accumulation and continuous innovation in independent R&D of innovative drugs and full-chain CRO/CDMO services for pharmaceuticals.
Hidden Unicorns—a new concept—represent high-potential enterprises critical to sci-tech cultivation. The report, the fourth of its kind, uses the Global Unicorn 500 database and Hidden Unicorn evaluation criteria (requiring original/disruptive technologies and irreplicable business models). Through AI-augmented analysis, the top 500 Hidden Unicorns in China were selected.
Since its founding, Jiangsu Vcare has focused on innovative drugs and advanced therapies, evolving into a dual-core enterprise (innovative drug R&D + full-chain CRO/CDMO services). It currently has5 clinical-stage Class I innovative drug projectsand10+ preclinical projects, with a pipeline centered on Vicagrel covering cardiovascular, oncology, and autoimmune diseases. Its CRO/CDMO arm serves 300+ global clients, operating the 130-mu (approx. 8.67 hectares) CDMO facility—Hubei Tianshu Pharmaceutical Co., Ltd.in a provincial chemical park—providing integrated services from advanced intermediates to APIs, and from CMC to clinical CRO and registration.
This recognition affirms Jiangsu Vcare’s "hardcore" R&D strength and future potential. The company will implement a "new quality productivity" strategy, advancing its dual-core model (innovative drugs + full-chain CRO/CDMO) to become a top-tier global pharmaceutical group.
Related News
27
2017
/
03
Vice Chairman of Political Consultative Conference of Wenzhou Ouhai District Visited Jiangsu Vcare
The delegation of Political Consultative Conference of Wenzhou Ouhai District, accompanied by vice chairman of Political Consultative Conference of Pukou Economic Development Zone visited Jiangsu Vcare Pharmaceutical Technology Co., Ltd. on the afternoon of March 27, 2017. Yongqiang Liu, the general manager of Jiangsu Vcare received the delegation. Mr. Liu introduced the company's development history and R&D progress. He focused on the progress of phase II clinical trials and the future market prospect of innovative drug Vicagrel. The delegation highly recognized Vcare's advanced equipment and facilities, harmonious human environment and comprehensive research and development capabilities.
View Details
14
2017
/
03
Jiangsu Vcare Held “Firefighting and First Aid” Training
Jiangsu Vcare invited Lei Wang, a special instructor of Nanjing Anqu Fire Education Center to give a “Firefighting and First Aid” course to new employees on March 14, 2017 and 26 new employees participated in the training. Mr. Wang collected a large number of fire cases and carefully analyzed the causes of these fires. He taught everyone how to deal with fires. His explanations made everyone fully aware of the importance and urgency of fire safety. At the same time, everyone had a better understanding of various fire extinguishers and their instructions.
View Details
Company Address:
No. 136, Huakang Road, Jiangbei New Area, Nanjing, P. R. China
Subsidiary NJVcare Website：
Scan to see
Copyright © JIANGSU VCARE PHARMATECH CO.,LTD.
Powerby：www.300.cn nanjing.300.cn